Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
CareDx, Inc

CareDx, Inc (CDNA) Stock Overview

Explore CareDx, Inc’s financial performance, market position, analyst ratings, and future outlook.

CDNA●NASDAQ
HealthcareMedical - Diagnostics & Research
$81.17
$0.40(0.50%)
U.S. Market opens in 1h 31m

CareDx, Inc (CDNA)

Meyka AI Score

Z

Key Financials

Market Cap4.3B
P/E Ratio32.35
EPS (TTM)$0.84
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$90.09
3 Months$107.68
1 Year Target$38.81

CDNA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of CareDx, Inc (NASDAQ: CDNA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CareDx, Inc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CDNA on the NASDAQ shows an RSI of 59.64, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $38.81 for the NASDAQ listing.

Key metrics behind CareDx, Inc's NASDAQ-traded stock include a P/E ratio of 32.35 and a market capitalization of 4.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CDNA on the NASDAQ.

Price Performance (NASDAQ: CDNA)

1-Day Change
0.50%
5-Day Change
4.22%
1-Month Change
27.49%
3-Month Change
71.86%
6-Month Change
276.66%
Year-to-Date (YTD) Change
330.84%
1-Year Change
383.73%
3-Year Change
924.87%
5-Year Change
72.12%
All-Time (Max) Change
796.91%

Contact Information

https://www.caredx.com
415 287 2300
8000 Marina Boulevard, Brisbane, CA, 94005

Company Facts

7,630 Employees
IPO DateJul 17, 2014
CountryUS
Actively Trading

Frequently Asked Questions